盐酸尼卡地平肠溶缓释微丸的研制
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Study on nicardipine hydrochloride intestinal-dissolved sustained-release pellets
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:将盐酸尼卡地平制成肠溶缓释固体分散体,以促进其在肠道内溶出,提高制剂的生物利用度。方法:以水溶性材料(PEG6000)和肠溶性材料(Ⅱ丙烯酸树脂)为混合载体,采用溶剂法制备了盐酸尼卡地平固体分散体。通过正交实验设计,筛选得到了具有理想肠溶缓释效果的处方。结果:盐酸尼卡地平制成的肠溶缓释固体分散体在人工肠液中3 h释放量为54.33%,10 h释放量为80.18%。其体外释药方式符合Higuchi 方程。DTA分析和X-射线粉末衍射证实药物以无定形态分散于载体中。结论:以固体分散体制备的肠溶缓释微丸具有促进药物溶出、定位缓慢释放的作用。

    Abstract:

    Objective: To prepare nicardipine hydrochloride solid dispersion to promote the dissolution and improve bioavailability of drugs in vivo and in vitro. Methods: Nicardipine hydrochloride solid dispersion was developed using Ⅱ acrylic resin and PEG6000 as mixed carrier by the solvent evaporating method. The orthogonal test was employed in the design of the formulations. Results: The percentage released of nicardipine hydrochloride solid dispersion in artificial intestinal liquid was 54.33%and 80.18%at 3 h and 10 h, respectively. The DTA and X-ray powder diffractometry showed that nicardipine hydrochloride was amorphously dispersed in the solid dispersion. The released profiles in vitro of the solid dispersion followed Higuchi equation. Conclusion: Nicardipine hydrochloride intestinal-dissolved sustained-release pellets are prepared by traditional method which combine the advantages of pellets and solid dispersion.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭